ERBB2 and non-small cell lung carcinoma: For example, ERBB2-mutant NSCLC were shown to preferentially internalize the HER2 receptor antibody–drug conjugate complex, and this has led to new studies in ERBB2-mutant solid tumors (which include gastric and oesophageal cancers, as shown here)(NCT04639219).